The uptake of N-(2-hydroxypropyl)-methacrylamide based homo, random and block copolymers by human multi-drug resistant breast adenocarcinoma cells

被引:89
作者
Barz, Matthias [1 ]
Luxenhofer, Robert [2 ]
Zentel, Rudolf [1 ]
Kabanov, Alexander V. [2 ]
机构
[1] Johannes Gutenberg Univ Mainz, Inst Organ Chem, D-55099 Mainz, Germany
[2] Univ Nebraska, Dept Pharmaceut Sci, Ctr Drug Delivery & Nanomed, Coll Pharm,Med Ctr, Omaha, NE 68198 USA
基金
美国国家卫生研究院;
关键词
Endocytosis; Structure-property relationship; Drug delivery; Polymer microstructure; RAFT polymerization; TRANSFER RADICAL POLYMERIZATION; MACROMOLECULAR THERAPEUTICS; INTERNALIZATION PATHWAYS; CELLULAR INTERNALIZATION; CANCER-CHEMOTHERAPY; DIBLOCK COPOLYMERS; MICELLE FORMATION; POLYMERS; DRUG; DESIGN;
D O I
10.1016/j.biomaterials.2009.06.058
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
A series of well-defined, fluorescently labelled homopolymers, random and block copolymers based on N-(2-hydroxypropyl)-methacrylamide were prepared by reversible addition-fragmentation chain transfer polymerization (RAFT polymerization). The polydispersity indexes for all polymers were in the range of 1.2-1.3 and the number average of the molar Mass (M-n) for each polymer was set to be in the range of 15-30 kDa. The cellular uptake of these polymers was investigated in the human multi-drug resistant breast adenocarcinoma cell line MCF7/ADR. The uptake greatly depended on the polymer molecular mass and structure. Specifically, smaller polymers (approx. 15 kDa) were taken up by the cells at much lower concentrations than larger polymers (approx. 30 kDa). Furthermore, for polymers of the same molar mass, the random copolymers were more easily internalized in cells than block copolymers or homopolymers. This is attributed to the fact that random copolymers form micelle-like aggregates by intra- and interchain interactions, which are smaller and less stable than the block copolymer structures in which the hydrophobic domain is buried and thus prevented from unspecific interaction with the cell membrane. Our findings underline the need for highly defined polymeric carriers and excipients for future applications in the field of nanomedicine. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5682 / 5690
页数:9
相关论文
共 46 条
[11]   The dawning era of polymer therapeutics [J].
Duncan, R .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (05) :347-360
[12]   Polymer conjugates as anticancer nanomedicines [J].
Duncan, Ruth .
NATURE REVIEWS CANCER, 2006, 6 (09) :688-701
[13]   Synthesis of pentafluorophenyl(meth)acrylate polymers:: New precursor polymers for the synthesis of multifunctional materials [J].
Eberhardt, M ;
Mruk, R ;
Zentel, R ;
Théato, P .
EUROPEAN POLYMER JOURNAL, 2005, 41 (07) :1569-1575
[14]   Cancer nanotechnology: Opportunities and challenges [J].
Ferrari, M .
NATURE REVIEWS CANCER, 2005, 5 (03) :161-171
[15]   HIGH POLYMERS OF ACRYLIC AND METHACRYLIC ESTERS OF N-HYDROXYSUCCINIMIDE AS POLYACRYLAMIDE AND POLYMETHACRYLAMIDE PRECURSORS [J].
FERRUTI, P ;
FERE, A ;
BETTELLI, A .
POLYMER, 1972, 13 (10) :462-&
[16]   The effect of particle design on cellular internalization pathways [J].
Gratton, Stephanie E. A. ;
Ropp, Patricia A. ;
Pohlhaus, Patrick D. ;
Luft, J. Christopher ;
Madden, Victoria J. ;
Napier, Mary E. ;
DeSimone, Joseph M. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (33) :11613-11618
[17]   Microfabricated Particles for Engineered Drug Therapies: Elucidation into the Mechanisms of Cellular Internalization of PRINT Particles [J].
Gratton, Stephanie E. A. ;
Napier, Mary E. ;
Ropp, Patricia A. ;
Tian, Shaomin ;
DeSimone, Joseph M. .
PHARMACEUTICAL RESEARCH, 2008, 25 (12) :2845-2852
[18]   Macromolecular therapeutics - Advantages and prospects with special emphasis on solid tumour targeting [J].
Greish, K ;
Fang, J ;
Inutsuka, T ;
Nagamitsu, A ;
Maeda, H .
CLINICAL PHARMACOKINETICS, 2003, 42 (13) :1089-1105
[19]   Polymer therapeutics: Concepts and applications [J].
Haag, R ;
Kratz, F .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2006, 45 (08) :1198-1215
[20]   Effect of pegylation on pharmaceuticals [J].
Harris, JM ;
Chess, RB .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (03) :214-221